Imunon, Inc. (CLSN)

1 member of Congress has disclosed 12 trades in Imunon, Inc. (CLSN) via STOCK Act filings. The most recent disclosure was a purchase by Roger Marshall on 16 June 2017. Aggregate disclosed activity totals roughly $48K in purchases and $48K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for CLSN
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for CLSN

5 transactions
Compliance: 0%
Roger Marshall16 Jun 20176 Aug 2018PurchaseStock$1,001 - $15,000N/A
Roger Marshall16 Jun 201710 Aug 2018PurchaseStock$1,001 - $15,000N/A
Roger Marshall16 Jun 201713 Aug 2020PurchaseStock$1,001 - $15,000N/A
Roger Marshall16 Jun 201713 Aug 2020SaleStock$1,001 - $15,000N/A
Roger Marshall16 Jun 20176 Aug 2018SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Stock Overview

Market Data

Market Cap

$14.47M

Volume

56.81K

Beta

2.26

P/E Ratio

-0.49

Fundamentals

EPS

$-3.97

Div. Yield

-

Open

$1.96

Day Range

$1.93 – $1.99

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Michael Tardugno
IPO Date
1993-10-27
Website
celsion.com

Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based imm...

Earnings

Recent Quarters

Q4 202229 Mar
EPS-
Q3 202214 Nov
EPS-
Q2 202215 Aug
EPS$-0.87
Beat 22.3%
Q1 202216 May
EPS$-1.82
Miss 83.8%
Q4 202131 Mar
EPS$-3.62
Miss 302.2%
Q3 202115 Nov
EPS$-0.90
Beat 25.0%
Q2 202112 Aug
EPS$-0.90
Beat 25.0%
Q1 202114 May
EPS$-1.35
Q4 202019 Mar
EPS$-0.75
Beat 61.5%
Q3 202016 Nov
EPS$-3.60
Miss 89.5%
Q2 202014 Aug
EPS$-2.70
Miss 28.6%
Q1 202015 May
EPS$-3.00
Miss 17.6%
Q4 201925 Mar
EPS$-1.50
Beat 49.1%
Q3 201914 Nov
EPS$-0.25
Beat 10.7%
Q2 201914 Aug
EPS$-0.29
Beat 9.4%
Q1 201915 May
EPS$-0.12
Beat 55.6%
Q4 201829 Mar
EPS$-0.28
Miss 100.0%
Q3 201814 Nov
EPS$-0.26
Miss 18.2%
Q2 201814 Aug
EPS$-0.46
Miss 70.4%
Q1 201811 May
EPS$-3.80
Q4 201727 Mar
EPS$-0.31
Miss 3.3%
Q3 201714 Nov
EPS$-0.70
Miss 25.0%
Q2 201715 Aug
EPS$-0.79
Miss 6.8%
Q1 201712 May
EPS$-1.68
Miss 28.2%
Q4 201616 Mar
EPS$-2.66
Miss 2.7%
Q3 201610 Nov
EPS$-3.22
Miss 13.0%
Q2 201615 Aug
EPS$-2.66
Beat 8.0%
Q1 201616 May
EPS$-3.36
Miss 13.1%
Q4 201530 Mar
EPS$-3.36
Miss 1.2%
Q3 20155 Nov
EPS$-2.66
Beat 28.1%
Q2 201510 Aug
EPS$-3.78
Beat 12.3%
Q1 201511 May
EPS$-0.35
Miss 6.1%
Q4 201412 Mar
EPS$-0.32
Beat 11.1%
Q3 201410 Nov
EPS$-0.35
Miss 9.4%
Q2 20147 Aug
EPS$-0.38
Miss 22.6%
Q1 20148 May
EPS$-4.62
Miss 37.5%
Q4 201313 Mar
EPS$-2.66
Beat 32.1%
Q3 201312 Nov
EPS$-4.20
Miss 33.3%
Q1 201330 Jun
EPS$3.77
Q1 20139 May
EPS$-7.56
Beat 25.0%
Q4 201218 Mar
EPS$-13.23
Miss 23.5%
Q3 201212 Nov
EPS$-11.34
Miss 3.9%
Q2 201214 Aug
EPS$-11.34
Beat 5.3%
Q1 201215 May
EPS$-11.97
Beat 8.1%
Q4 201115 Mar
EPS$-11.34
Beat 25.0%
Q3 201110 Nov
EPS$-15.12
Beat 4.0%
Q1 201130 Jun
EPS$-407.41
Q4 201031 Mar
EPS$-252.60
Q3 201031 Dec
EPS$-0.42
Q3 201015 Nov
EPS$-23.94
Miss 18.8%
Q2 20103 Aug
EPS$-13.86
Beat 42.1%
Q1 20104 May
EPS$-31.50
Miss 56.3%
Q4 200917 Feb
EPS$-11.97
Beat 47.2%
Q2 200930 Sept
EPS$-440.62
Q1 200930 Jun
EPS$-433.73
Q4 200831 Mar
EPS$-336.05
Q3 200831 Dec
EPS$-86.99
Q2 200830 Sept
EPS$-404.14
Q1 200830 Jun
EPS$-226.34
Q4 200731 Mar
EPS$-380.31
Q3 200731 Dec
EPS$-237.21
Q2 200730 Sept
EPS$-317.27
Q1 200730 Jun
EPS$3593.22
Q4 200631 Mar
EPS$-207.32
Q3 200631 Dec
EPS$-95.73
Q2 200630 Sept
EPS$-87.23
Q1 200630 Jun
EPS$-327.79
Q4 200531 Mar
EPS$-157.04
Q3 200531 Dec
EPS$-187.17
Q2 200530 Sept
EPS$-172.13
Q1 200530 Jun
EPS$-211.78
Q4 200431 Mar
EPS$-194.23
Q3 200431 Dec
EPS$-280.13
Q2 200430 Sept
EPS$-292.14
Q1 200430 Jun
EPS$-130.14
Q4 200331 Mar
EPS$-561.17
Q2 200330 Sept
EPS$-30.53
Q1 200330 Jun
EPS$-352.44
Q4 200231 Mar
EPS$-624.12
Q4 200215 Feb
EPS$-288.31
Miss 1425.4%
Q2 200230 Sept
EPS$-17.22
Q1 200230 Jun
EPS$-412.98
Q4 200131 Mar
EPS$-593.94
Q3 200131 Dec
EPS$-298.93
Q2 200130 Sept
EPS$-28.37
Q1 200130 Jun
EPS$-299.48
Q4 200031 Mar
EPS$-310.18
Q4 20008 Feb
EPS$-18.90
Beat 0.0%
Q3 20001 Oct
EPS$-28.35
Miss 110.7%
Q1 200030 Jun
EPS$-216.34
Q4 199931 Mar
EPS$-244.02
Q3 199931 Dec
EPS$-237.03
Q2 199930 Sept
EPS$-14.25
Q1 199930 Jun
EPS$-129.21
Q4 199831 Mar
EPS$-13.20
Q3 199831 Dec
EPS$-13.25
Q2 199830 Sept
EPS$-24.00
Q1 199830 Jun
EPS$-40.00
Q4 199731 Mar
EPS$-26.25
Q3 199731 Dec
EPS$-28.33
Q2 199730 Sept
EPS$-43.50
Q1 199730 Jun
EPS$-27.67
Q4 199631 Mar
EPS$-18.67
Q3 199631 Dec
EPS$-18.00
Q2 199630 Sept
EPS$-18.83

No dividend data available for this stock.

Stock Splits

Split History

1 Mar 2022Reverse Split
Ratio1:15
30 May 2017Reverse Split
Ratio1:14
29 Oct 2013Reverse Split
Ratio111:500
28 Feb 2006Reverse Split
Ratio1:15

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about CLSN

Which members of Congress have traded CLSN?
1 member of Congress has disclosed 12 trade in Imunon, Inc. (CLSN) under the STOCK Act: Roger Marshall.
When was CLSN most recently disclosed by Congress?
The most recent CLSN disclosure was a purchase by Roger Marshall on 16 June 2017.
What is the total disclosed congressional trading volume for CLSN?
Members of Congress have disclosed approximately $48K in CLSN purchases and $48K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in CLSN?
This CLSN page updates as soon as new STOCK Act disclosures are filed for Imunon, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.